Article
Multi-omics SMR and experimental supportive analyses decipher causal drivers hepatocellular carcinoma.
BMC cancer - 16 Feb 2026
Yang Zhiya, Li Tingyang, Shen Jiayun, Huang Yao, Lei Chao, Yu Jiarui, Ma Zhaochen, Zhang Ming, Li Ying
Abstract excerpt
BACKGROUND: Hepatocellular carcinoma (HCC) is a highly prevalent and fatal digestive system malignancy, challenging to treat due to its latent onset and non-specific symptoms in advanced stages. Somatic mutations play a crucial role in hepatocarcinogenesis, with nearly half of HCC patients carrying oncogenic driver mutations such as TP53, CTNNB1, or TERT. In parallel, germline susceptibility variants identified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
